Newsletter | May 9, 2026

05.09.26 -- Clinical Leader - Best Of April

APRIL'S BEST FEATURED EDITORIAL

From RWD To Real-World Impact: Evidence Pharma Actually Needs

Learn how companies that treat RWE as an operational capability will be better positioned to design more efficient trials, accelerate therapy adoption, strengthen payer negotiations, and demonstrate value across the healthcare ecosystem.

Management And Oversight Become Must-Haves For Success

Site management and site oversight are often used interchangeably in clinical research, but they mean different things. Explore their roles and importance in ensuring successful sites and trials.

Adapt Or Die: Best Practices In Designing A Phase 3 Oncology Trial

Discover how adaptive trial design can deliver greater operational efficiency, improved efficacy outcomes, and enhanced sponsor affordability across the drug development life cycle.

APRIL'S BEST INDUSTRY INSIGHTS

AI, Open Source, And The Future Of Biostatistics

Embrace the transformation by integrating AI, open-source innovation, and evolving data standards to shape the future of statistical programming and drive the next wave of clinical discovery.

Optimizing Clinical Data: Reducing Redundancy For Efficiency

Enabling sites to focus solely on critical data facilitates faster data entry, reduces queries, and fosters better relationships between sponsors, CROs, and sites.

2026 State Of Clinical Trial Technology: The 5 Strategic Imperatives

AI acceleration and digital fragmentation are reshaping clinical trials. Discover five imperatives driving interoperability, smarter site enablement, and data‑ready workflows for future‑ready operations.

APRIL'S BEST SOLUTIONS

Delivering The Digital Future

Managing Execution Of A Phase III Clinical Trial

Power Patient-Focused Data Collection Across Hybrid Clinical Trials

Connect With Clinical Leader: